Direxion Daily S&P Biotech Bear 3X Shares (LABD) — ()
Key Metrics
News
Top Performing Leveraged/Inverse ETFs: 05/11/2025
Published: by:
Sentiment: Neutral ()
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Read More
5 Leveraged/Inverse ETFs That Gained More Than 25% in April
Published: by:
Sentiment: Positive ()
Market volatility boosts demand for leveraged and inverse-leveraged ETFs. A few of them gained more than 25% last month.
Read More
Leveraged ETF Winners Amid Wall Street's Worst Week Since 2020
Published: by:
Sentiment: Negative ()
Inverse and volatility ETFs won in the worst week of Wall Street since 2020.
Read More
About Direxion Daily S&P Biotech Bear 3X Shares LABD
The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.